Dr. Reiter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCLA Medical Center
10833 LeConte Ave, 66-128 CHS
Los Angeles, CA 90095Phone+1 310-794-7224Fax+1 310-794-7224
Summary
- Dr. Robert Reiter is an urologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica. He received his medical degree from Stanford University School of Medicine and has been in practice 29 years. He also speaks multiple languages, including French and Spanish. He specializes in surgical oncology and is experienced in urologic oncology and minimally invasive urologic surgery.
Education & Training
Baylor College of MedicineResidency, Urology, 1990 - 1995
Stanford Health Care-Sponsored Stanford UniversityResidency, Urology, 1989 - 1990- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1988 - 1989
Stanford University School of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 1989 - 2025- American Board of Urology Urology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2004
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 185 citationsDetection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance ImagingDavid C. Johnson, Steven S. Raman, Sohrab Afshari Mirak, Lorna Kwan, Amirhossein Mohammadian Bajgiran
European Urology. 2019-05-01 - 339 citationsProstate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.Zhennan Gu, George Thomas, Joyce Yamashiro, Shintaku Ip, Frederick J. Dorey
Oncogene. 2000-03-02 - 69 citationsProstate stem cell antigen is a putative target for immunotherapy in pancreatic cancer.Moritz N. Wente, Anjali Jain, Evelyn A. Kono, Pascal O. Berberat, Thomas Giese
Pancreas. 2005-08-01
Journal Articles
- Near-Infrared-Dye Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse ModelsRobert Reiter, MD, Clinical Cancer Research
Press Mentions
What Everyone Needs to Know About Prostate CancerAugust 26th, 2024
UCLA Prostate Cancer Program Receives $8.7 Million Grant from NCIOctober 31st, 2019
University Receives Prostate Cancer-Fighting GrantOctober 31st, 2019- Join now to see all
Other Languages
- French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
